The lithotripsy devices market size in Europe is expected to be worth USD 890 million by 2028 from USD 700 million in 2023, growing at a CAGR of 4.87% from 2023 to 2028.
The growing patient population suffering from kidney stone disorder treatment in Europe majorly propels the European lithotripsy devices market growth. Approximately one in eleven individuals in the United Kingdom are at risk of developing kidney stones during their lifetime. Lifestyle modifications, unhealthy dietary habits, obesity, hormonal changes, and the prolonged use of certain medications are among the leading causes of kidney stones in the population. Patients with large stones in their kidneys typically opt for lithotripsy treatment, which facilitates the fragmentation of stones and their passage through the urine. The growing geriatric population is also contributing to the demand for lithotripsy devices and boosting regional market growth. As age increases the likelihood of kidney stone disease. Furthermore, the prevalence of diabetes among the elderly is also increasing, resulting in uric acid stone formation in many individuals and is anticipated to add fuel to the growth rate of the European market.
The growing adoption of this technology by numerous healthcare providers in Europe further fuels the growth rate of the European market growth. Lithotripsy is a minimally invasive surgical procedure that effectively treats kidney stone diseases without the need for incisions. Patients who are averse to traditional surgeries often opt for lithotripsy treatment as it involves less recovery time and shorter hospital stays. The growing development of advanced lithotripsy devices that offer more precise and effective treatment adds fuel to the growth rate of the regional market. Researchers and manufacturers are focusing on incorporating advanced technologies such as lasers and sophisticated cameras to provide better visibility of the kidney's stone area and deliver precise shock waves for treatment.
However, the scarcity of skilled professionals for using lithotripsy devices and the lack of awareness about the treatment among the rural population majorly hamper the growth rate of the European market. In addition, side effects of using lithotripsy devices in the kidney stone procedure such as shock waves are infection, bleeding around the kidney and urinary tract issues is another significant obstacle to the growth rate of the European market. Furthermore, long-time approval for novel devices, lack of proper infrastructure facilities, and strict government rules inhibit the growth rate of the European market.
This research report on the Europe Lithotripsy devices market has been segmented and sub-segmented into the following categories.
By Product Type:
By End-user:
By Application:
By Country:
The European regional market accounted for the second-largest share of the worldwide market in 2022 and is estimated to grow at a prominent CAGR during the forecast period. In 2022, the UK dominated the European market, followed by Germany. The UK lithotripsy devices market is anticipated to account for the leading share of the European market during the forecast period owing to the growing number of approvals of novel devices and rising awareness about the benefits of using lithotripsy devices among UK healthcare professionals and people. The growing number of UK government initiatives and reimbursement policies have also supported the adoption of advanced devices for kidney stone treatment. The growing number of awareness programs by the government, healthcare organizations and key players to promote the adoption of lithotripsy procedures through social media and television advertisements further boost the growth rate of the UK market.
The growing number of specialized hospitals and clinics for kidney stone treatment contributes to the growth rate of the UK market. Moreover, the increasing number of manufacturing facilities in the UK is another favorable factor for UK market growth. Germany is predicted to hold a substantial share of the European market and is estimated to grow at a healthy CAGR during the forecast period due to the establishment of training centers that educate healthcare professionals on operating advanced lithotripsy devices, making the treatment less complicated and more efficient.
KEY MARKET PLAYERS:
Boston Scientific Corporation, Siemens AG, Cook Medical Inc., Olympus Corporation and Dornier MedTech GmbH are some of the noteworthy companies in the European lithotripsy devices market.
Frequently Asked Questions
The increasing prevalence of kidney stone disorder, the growing geriatric population, and the adoption of lithotripsy devices by healthcare providers are the primary factors driving the growth of the Europe lithotripsy devices market.
The United Kingdom and Germany have a significant share in the Europe lithotripsy devices market due to the presence of specialized hospitals and clinics for kidney stone treatment, increasing awareness programs, and the government's support to adopt novel devices for kidney stone diseases.
Some of the top companies in the Europe lithotripsy devices market include Boston Scientific Corporation, DirexGroup, Lumenis Ltd., Olympus Corporation, and Richard Wolf GmbH.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region